There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on IQVIA Holdings (IQV – Research Report), Evolent Health (EVH – Research Report) and InMode (INMD – Research Report) with bullish sentiments.
IQVIA Holdings (IQV)
In a report released yesterday, Luke Sergott from Barclays maintained a Buy rating on IQVIA Holdings, with a price target of $265.00. The company’s shares closed last Wednesday at $243.47, close to its 52-week high of $243.82.
According to TipRanks.com, Sergott is a 1-star analyst with an average return of
The word on The Street in general, suggests a Strong Buy analyst consensus rating for IQVIA Holdings with a $252.38 average price target, which is a 13.2% upside from current levels. In a report issued on February 13, BTIG also initiated coverage with a Buy rating on the stock with a $285.00 price target.
See Insiders’ Hot Stocks on TipRanks >>
Evolent Health (EVH)
In a report released yesterday, Stephanie Davis from Barclays maintained a Buy rating on Evolent Health, with a price target of $39.00. The company’s shares closed last Wednesday at $30.84.
According to TipRanks.com, Davis has 0 stars on 0-5 stars ranking scale with an average return of
Evolent Health has an analyst consensus of Strong Buy, with a price target consensus of $45.75, implying a 48.1% upside from current levels. In a report issued on January 30, TD Cowen also maintained a Buy rating on the stock with a $63.00 price target.
InMode (INMD)
In a report released yesterday, Matt Miksic from Barclays maintained a Buy rating on InMode, with a price target of $34.00. The company’s shares closed last Wednesday at $22.90, close to its 52-week low of $18.57.
According to TipRanks.com, Miksic is a 5-star analyst with an average return of
InMode has an analyst consensus of Moderate Buy, with a price target consensus of $31.00, which is a 29.2% upside from current levels. In a report issued on February 13, Robert W. Baird also maintained a Buy rating on the stock with a $30.00 price target.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Read More on IQV:
